...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Eligibility for registered accounts in Canada
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Hi Kelsee,

No problem - the information I shared is information that was provided by the company.  I am not a tax expert (nor am I offering any advice).  Everyone should do their own due deligence and use the information in accordance with the CRA rules.

All the best.

Long

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply